{'text': 'FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Beta-Thalassemia', 'publisher': {'href': 'https://www.businesswire.com', 'title': 'Business Wire'}, 'created_at': 'Mon, 18 May 2015 07:00:00 GMT', 'description': 'FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Beta-Thalassemia  Business Wire', 'url': 'https://news.google.com/rss/articles/CBMi8AFBVV95cUxPYnFfMjRyNHJ4ZHQtdGcxRnhiSExRdlFuZ2d3X0h4OGUxaVVMcnFzbk5mbThZZUZrN3JkYTBYNUJNZXlRQklhX1NoWTlDbjBlOUs2bGVnakFGZGM0X1Jla3VOOFBQOWdkY25nNDZKdlRQSEV6WXZvOGtWVDQ2QWxBMXEwMWlidmhxUUNlUkhWUlBzcHZHMkhFMnBMc3E0bHU3ZGszU1FQR1Q1ZFNPOWZHa3ZZa3FSWWZyeHJ0bVBkaEJvYkJuUmdkVVhkTzFFT2tGc0Q2bk1TM0VfYm1sU1ZyRmNIX1ZJX0kxNXE1dzNCWXc?oc=5&hl=en-US&gl=US&ceid=US:en'}
